February 14, 2025
Board of Directors
Review and approval of KPIs* for Q4 2024
————————————————————————————-
March 31, 2025
Board of Directors
Approval of the draft annual financial statements and the consolidated group financial statements as of December 31, 2024
————————————————————————————-
April 30, 2025
Annual Shareholders’ Meeting
Approval of the annual financial statements as of December 31, 2024
————————————————————————————-
May 14, 2025
Board of Directors
Review and approval of KPIs* for Q1 2025
————————————————————————————-
August 1, 2025
Board of Directors
Review and approval of KPIs* for Q2 2025
————————————————————————————-
September 19, 2025
Board of Directors
Approval of the consolidated semi-annual financial report as of June 30, 2025, voluntarily subjected to limited audit review
————————————————————————————-
November 14, 2024
Board of Directors
Review and approval of KPIs* for Q3 2025
————————————————————————————-
February 13, 2026
Board of Directors
Review and approval of KPIs* for Q4 2025
*The monitored KPIs will include Consolidated Net Sales, Consolidated Total Revenues, Consolidated Net Financial Position, Consolidated Order Book, and Consolidated EBITDA – consolidated managerial data not subject to audit review
—